200 related articles for article (PubMed ID: 30027279)
21. [The role of surgery in the treatment of cutaneous melanoma].
Guggenheim M; Dummer R; Giovanoli P
Praxis (Bern 1994); 2011 Jul; 100(15):911-6. PubMed ID: 21792806
[TBL] [Abstract][Full Text] [Related]
22. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
[TBL] [Abstract][Full Text] [Related]
23. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.
Essner R
Expert Rev Anticancer Ther; 2010 May; 10(5):723-8. PubMed ID: 20470004
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma.
Barker CA
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):11-12. PubMed ID: 28586947
[No Abstract] [Full Text] [Related]
25. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
26. Five-year follow-up of 16 melanoma patients with a Starz I-involved sentinel node in whom completion lymph node dissection was omitted.
Veenstra HJ; Brouwer OR; van der Ploeg IM; Kroon BB; Nieweg OE
Melanoma Res; 2012 Dec; 22(6):436-9. PubMed ID: 22975764
[TBL] [Abstract][Full Text] [Related]
27. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.
Thomas JM
J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650
[No Abstract] [Full Text] [Related]
28. Comparative effectiveness in melanoma.
Russel MC; Delman KA
Cancer Treat Res; 2015; 164():31-49. PubMed ID: 25677017
[TBL] [Abstract][Full Text] [Related]
29. Total cell necrosis of metastatic malignant melanoma at the regional lymph node in a patient treatment with nivolumab.
Komori T; Otsuka A; Kaku Y; Irie H; Honda T; Hirata M; Kataoka TR; Kabashima K
J Dermatol; 2018 Jan; 45(1):e11-e12. PubMed ID: 28944586
[No Abstract] [Full Text] [Related]
30. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
Coldiron BM; Dinehart S; Rogers HW
Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
[TBL] [Abstract][Full Text] [Related]
31. [Guidelines for stage I to III melanoma].
Guillot B; Dalac S; Denis M; Dupuy A; Emile JF; De La Fouchardiere A; Hindie E; Jouary T; Lassau N; Mirabel X; Piperno Neumann S; De Raucourt S; Vanwijck R
Bull Cancer; 2016 Sep; 103(9):743-52. PubMed ID: 27456259
[No Abstract] [Full Text] [Related]
32. Current and planned multicenter trials for patients with primary or metastatic melanoma.
Sondak VK; Han D; Deneve J; Kudchadkar R
J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
[TBL] [Abstract][Full Text] [Related]
33. Multiple "halo nevi" occurring during pembrolizumab treatment for metastatic melanoma.
Nicolétis-Lombart I; Kervarrec T; Zaragoza J; Machet MC; Samimi M
Int J Dermatol; 2019 Jun; 58(6):739-741. PubMed ID: 30229873
[No Abstract] [Full Text] [Related]
34. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
[TBL] [Abstract][Full Text] [Related]
35. Update on the use of sentinel node biopsy in patients with melanoma: who and how.
Chao C; McMasters KM
Curr Opin Oncol; 2002 Mar; 14(2):217-20. PubMed ID: 11880714
[TBL] [Abstract][Full Text] [Related]
36. Melanoma--part 2: management.
Thirlwell C; Nathan P
BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
[No Abstract] [Full Text] [Related]
37. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.
Dummer R; Siano M; Hunger RE; Lindenblatt N; Braun R; Michielin O; Mihic-Probst D; von Moos R; Najafi Y; Guckenberger M; Arnold A
Swiss Med Wkly; 2016; 146():w14279. PubMed ID: 26901103
[TBL] [Abstract][Full Text] [Related]
38. [Locally advanced and metastatic melanoma : novelties].
Huber A; Latifyan S; Nikolopoulou A; Homicsko K; Berthod G; Michielin O; Özdemir BC
Rev Med Suisse; 2020 May; 16(695):1092-1097. PubMed ID: 32462837
[TBL] [Abstract][Full Text] [Related]
39. Melanoma patients with melanoma micrometastases in sentinel node that refused completion lymphadenectomy.
Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Farfaglia R; Pizzocaro C; Ungari M; Calzavara-Pinton PG
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1008-9. PubMed ID: 18201174
[No Abstract] [Full Text] [Related]
40. Can histologic parameters of melanoma metastases in sentinel lymph nodes reliably select patients who can be safely spared completion lymph node dissection?
Murali R; Thompson JF; Scolyer RA
Ann Surg; 2010 Jun; 251(6):1188-9; author reply 1189-90. PubMed ID: 20485116
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
